Concurrent gemcitabine+S-1 neoadjuvant chemotherapy contributes to the improved survival of patients with small borderline-resectable pancreatic cancer tumors

Surgery Today ◽  
2016 ◽  
Vol 46 (11) ◽  
pp. 1282-1289 ◽  
Author(s):  
Toshihiko Masui ◽  
Ryuichiro Doi ◽  
Yoshiya Kawaguchi ◽  
Asahi Sato ◽  
Kenzo Nakano ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Resectable Pancreatic Cancer ◽  
Borderline Resectable ◽  
Borderline Resectable Pancreatic Cancer

Neoadjuvant chemotherapy with gemcitabine and S1 (NAC-GS) for borderline resectable pancreatic cancer

Pancreatology ◽  
2016 ◽  
Vol 16 (4) ◽  
pp. S18
Author(s):  
Fuyuhiko Motoi ◽  
Tatsuyuki Takadate ◽  
Shimpei Maeda ◽  
Kyohei Ariake ◽  
Kunihiro Masuda ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Resectable Pancreatic Cancer ◽  
Borderline Resectable ◽  
Borderline Resectable Pancreatic Cancer

scholarly journals 410 - Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy

2018 ◽  
Vol 154 (6) ◽  
pp. S-1265
Author(s):  
Ammar A. Javed ◽  
Ayat Siddique ◽  
Alex Blair ◽  
Lindsay Parish ◽  
Richard Burkhart ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Resectable Pancreatic Cancer ◽  
Borderline Resectable ◽  
Borderline Resectable Pancreatic Cancer
Sign in / Sign up

Export Citation Format

Share Document